当前蛋白身份:Q03405 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2FD6 Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an anti-upar antibody at 1.9 A 提交 2005-12-13 Assembly 1 其他组合 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 U 23–297(275 aa) 片段:residues 23-297
未记录 SO4 SULFATE ION × 1 ETX 2-ETHOXYETHANOL × 3 EDO 1,2-ETHANEDIOL × 2 PGE TRIETHYLENE GLYCOL × 1 NDG 2-acetamido-2-deoxy-alpha-D-glucopyranose × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 6.5;298 K;4% PEG4000, 5% ethylene glycol, 5% methanol, 0.05% sodium azide, 50 mM cacodylate, pH 6.5, MICRODIALYSIS, temperature 298K
分辨率 1.90 Å R-free 0.276
2FD6 Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an anti-upar antibody at 1.9 A 提交 2005-12-13 Assembly 2 其他组合 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 U 23–297(275 aa) 片段:residues 23-297
未记录 SO4 SULFATE ION × 1 ETX 2-ETHOXYETHANOL × 3 EDO 1,2-ETHANEDIOL × 2 PGE TRIETHYLENE GLYCOL × 1 NDG 2-acetamido-2-deoxy-alpha-D-glucopyranose × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 6.5;298 K;4% PEG4000, 5% ethylene glycol, 5% methanol, 0.05% sodium azide, 50 mM cacodylate, pH 6.5, MICRODIALYSIS, temperature 298K
分辨率 1.90 Å R-free 0.276
2I9B Crystal structure of ATF-urokinase receptor complex 提交 2006-09-05 Assembly 1 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 23–299(277 aa) 片段:UPAR, residues 23-299
突变:N162Q, N172Q, N200Q, N233Q SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;22.5% w/v PEG3350, 200 mM ammonium sulfate, 100 mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.80 Å R-free 0.265
2I9B Crystal structure of ATF-urokinase receptor complex 提交 2006-09-05 Assembly 2 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 23–299(277 aa) 片段:UPAR, residues 23-299
突变:N162Q, N172Q, N200Q, N233Q SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;22.5% w/v PEG3350, 200 mM ammonium sulfate, 100 mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.80 Å R-free 0.265
2I9B Crystal structure of ATF-urokinase receptor complex 提交 2006-09-05 Assembly 3 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 23–299(277 aa) 片段:UPAR, residues 23-299
突变:N162Q, N172Q, N200Q, N233Q 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;22.5% w/v PEG3350, 200 mM ammonium sulfate, 100 mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.80 Å R-free 0.265
2I9B Crystal structure of ATF-urokinase receptor complex 提交 2006-09-05 Assembly 4 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 23–299(277 aa) 片段:UPAR, residues 23-299
突变:N162Q, N172Q, N200Q, N233Q 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;22.5% w/v PEG3350, 200 mM ammonium sulfate, 100 mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.80 Å R-free 0.265
3BT1 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 1 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 U 23–303(281 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;12% PEG 3350, 50mM HEPES pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.80 Å R-free 0.308
3BT2 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 1 其他组合 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 U 23–303(281 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.50 Å R-free 0.272
3BT2 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 2 其他组合 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 U 23–303(281 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.50 Å R-free 0.272
3U73 Crystal structure of stabilized human uPAR mutant in complex with ATF 提交 2011-10-13 Assembly 1 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 U 23–305(283 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;295 K;0.2M NaCl, 100mM HEPES, pH7.4, 1.8 M ammonium sulfate, vapor diffusion, sitting drop, temperature 295.0K
分辨率 3.19 Å R-free 0.258
3U74 Crystal structure of stabilized human uPAR mutant 提交 2011-10-13 Assembly 1 其他组合 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 U 23–305(283 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;295 K;100 mM HEPES, pH 7.5, 2% (w/v) PEG400, 2 M ammonium sulfate, vapor diffusion, sitting drop, temperature 295.0K
分辨率 2.39 Å R-free 0.252
4K24 Structure of anti-uPAR Fab ATN-658 in complex with uPAR 提交 2013-04-08 Assembly 1 其他组合 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 U 23–303(281 aa) 片段:UNP residues 23-303
未记录 MAN alpha-D-mannopyranose × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;0.1M HEPES pH 7.5, 55%(v/v) Tacsimate, 2%(v/v) 2-methyl-1,3-propanediol, vapor diffusion, sitting drop, temperature 295K
分辨率 4.50 Å R-free 0.275
4QTI Crystal structure of human uPAR in complex with anti-uPAR Fab 8B12 提交 2014-07-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 U 23–305(283 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;298 K;48% MPD, 100mM Tris, 100mM NaCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
分辨率 3.00 Å R-free 0.296
7E17 Structure of dimeric uPAR 提交 2021-02-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 23–299(277 aa)
链 B 23–299(277 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;295 K;1.8-2.2 M ammonium sulphate in 50 mM sodium acetate at pH 4.5oC5.2
分辨率 2.96 Å R-free 0.299
7V63 Structure of dimeric uPAR at low pH 提交 2021-08-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 23–299(277 aa)
链 B 23–299(277 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;295 K;1.8-2.2 M ammonium sulphate in 50 mM sodium acetate at pH 4.5-5.2
分辨率 2.91 Å R-free 0.273
9YC5 Human uPAR bound to the Fab fragment of targeted cancer therapeutic antibody FL1 提交 2025-09-18 Assembly 1 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 23–305(283 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;20mM Tris, 150mM NaCl, 2.5% Glycerol, 1mM EDTA, pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.94 Å
9YC6 Mutant human uPAR bound to the Fab fragment of the targeted cancer therapeutic antibody FL1 提交 2025-09-18 Assembly 1 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 U 23–305(283 aa)
突变:H47C, N259C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;20mM Tris, 150mM NaCl, 2.5% Glycerol, 1mM EDTA, pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.80 Å